Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause Immune-mediated enterocolitis? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Immune-mediated enterocolitis have been filed in association with TREMELIMUMAB\TREMELIMUMAB-ACTL. This represents 5.4% of all adverse event reports for TREMELIMUMAB\TREMELIMUMAB-ACTL.
63
Reports of Immune-mediated enterocolitis with TREMELIMUMAB\TREMELIMUMAB-ACTL
5.4%
of all TREMELIMUMAB\TREMELIMUMAB-ACTL reports
18
Deaths
40
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From TREMELIMUMAB\TREMELIMUMAB-ACTL?
Of the 63 reports, 18 (28.6%) resulted in death, 40 (63.5%) required hospitalization, and 19 (30.2%) were considered life-threatening.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB\TREMELIMUMAB-ACTL. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause?
Diarrhoea (109)
Death (106)
Malignant neoplasm progression (101)
Cytokine release syndrome (86)
Liver disorder (62)
Pyrexia (61)
Rash (60)
Colitis (47)
Immune-mediated hepatic disorder (45)
Interstitial lung disease (41)
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
ATEZOLIZUMAB (156)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)
Which TREMELIMUMAB\TREMELIMUMAB-ACTL Alternatives Have Lower Immune-mediated enterocolitis Risk?
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRENBOLONE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREOSULFAN
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL DIOLAMINE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRETINOIN